These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8681976)

  • 21. Alternative dosing strategy for aminoglycosides: impact on efficacy, nephrotoxicity, and ototoxicity.
    Chan GL
    DICP; 1989 Oct; 23(10):788-94. PubMed ID: 2683419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single daily dosing of aminoglycosides.
    Preston SL; Briceland LL
    Pharmacotherapy; 1995; 15(3):297-316. PubMed ID: 7667165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone.
    ter Braak EW; de Vries PJ; Bouter KP; van der Vegt SG; Dorrestein GC; Nortier JW; van Dijk A; Verkooyen RP; Verbrugh HA
    Am J Med; 1990 Jul; 89(1):58-66. PubMed ID: 2195890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides.
    Bailey TC; Little JR; Littenberg B; Reichley RM; Dunagan WC
    Clin Infect Dis; 1997 May; 24(5):786-95. PubMed ID: 9142771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
    Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
    Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What is the evidence for once-daily aminoglycoside therapy?
    Barclay ML; Begg EJ; Hickling KG
    Clin Pharmacokinet; 1994 Jul; 27(1):32-48. PubMed ID: 7955770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients.
    Koo J; Tight R; Rajkumar V; Hawa Z
    Am J Med; 1996 Aug; 101(2):177-83. PubMed ID: 8757358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review.
    Hatala R; Dinh TT; Cook DJ
    Clin Infect Dis; 1997 May; 24(5):810-5. PubMed ID: 9142773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides.
    Ali MZ; Goetz MB
    Clin Infect Dis; 1997 May; 24(5):796-809. PubMed ID: 9142772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Once-daily dosage of aminoglycosides--a therapeutic simplification and an economical benefit].
    Berild D; Sjursen H; Digranes A
    Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3152-6. PubMed ID: 10522483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aminoglycosides in cystic fibrosis: a descriptive study of current practice in Australia.
    Phillips JA; Bell SC
    Intern Med J; 2001; 31(1):23-6. PubMed ID: 11478352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?
    Barclay ML; Kirkpatrick CM; Begg EJ
    Clin Pharmacokinet; 1999 Feb; 36(2):89-98. PubMed ID: 10092956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Campoli-Richards DM; Chaplin S; Sayce RH; Goa KL
    Drugs; 1989 Nov; 38(5):703-56. PubMed ID: 2689137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety.
    Galløe AM; Graudal N; Christensen HR; Kampmann JP
    Eur J Clin Pharmacol; 1995; 48(1):39-43. PubMed ID: 7621846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982.
    Kahlmeter G; Dahlager JI
    J Antimicrob Chemother; 1984 Jan; 13 Suppl A():9-22. PubMed ID: 6365884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity?
    Nordström L; Ringberg H; Cronberg S; Tjernström O; Walder M
    J Antimicrob Chemother; 1990 Jan; 25(1):159-73. PubMed ID: 2108113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
    Prescott WA; Nagel JL
    Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Once-daily gentamicin versus once-daily netilmicin in patients with serious infections--a randomized clinical trial.
    Prins JM; Büller HR; Kuijper EJ; Tange RA; Speelman P
    J Antimicrob Chemother; 1994 Apr; 33(4):823-35. PubMed ID: 8056701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoglycoside monitoring in the once- or twice-daily era. The Dutch situation considered.
    Janknegt R
    Pharm World Sci; 1993 Aug; 15(4):151-5. PubMed ID: 8220298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Netilmicin sulfate: a comparative evaluation of antimicrobial activity, pharmacokinetics, adverse reactions and clinical efficacy.
    Craig WA; Gudmundsson S; Reich RM
    Pharmacotherapy; 1983; 3(6):305-15. PubMed ID: 6361701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.